To evaluate the change in parathyroid function during long-term hemodialysis, c-PTH and other related parameters were evaluated in 38 stable patients receiving maintenance hemodialysis for more than 10 years. At the start of hemodialysis, there was a significant negative correlation between c-PTH level and age (p<0.05), and c-PTH level was lower in elderly patients. Patients showing a c-PTH level more than 10ng/m
l were judged to be advanced hyperparathyroidism. Based on this criteria, 17 of 38 (44.7%) patients developed hyperparathyroidism during the 10-year follow-up. Factors that affected the occurrence of hyperparathyroidism were analyzed. It was revealed that the incidence of hyperparathyroidism were significantly less in patients with higher serum calcium levels (≥9.0mg/d
l) than in those with lower serum calcium levels (<9.0mg/d
l). In patients treated with vitamin D for more than 60% of their total dialysis treatment terms, the incidence of hyperparathyroidism was significantly less compared to those with less than 60% (p<0.0005). There was a significant positive correlation between the duration of vitamin D treatment and the serum calcium level (p<0.005). Meanwhile, there was no significant correlation between the occurrence of hyperparathyroidism and the serum inorganic phosphorus level.
These results suggest that the longer the duration of hemodialysis, the higher the c-PTH level in most patients, and the risk of developing hyperparathyroidism is inevitable. To prevent this complication, we recommend the maintaining serum calcium level to be more than 9.0mg/d
l with vitamin D supplementation.
View full abstract